TriSalus Life Sciences (TLSIW) Stock Price, News & Analysis

Company Overview

TriSalus Life Sciences, Inc. is a clinical-stage medical device company focused on developing minimally invasive technologies to enhance the precision and efficacy of cancer radiation therapy. The company’s lead product, the TriMark™ Tissue Marker System, is designed to provide high-visibility soft-tissue fiducial markers that assist oncologists in accurately targeting tumors during radiotherapy. By deploying bio-absorbable markers directly into tumor beds, TriSalus aims to improve treatment planning, patient comfort and long-term follow-up imaging.

Founded in 2015 and headquartered in Plymouth, Minnesota, TriSalus Life Sciences pursues a platform approach to oncology treatment, with research and development efforts centered on novel delivery devices and advanced imaging solutions. In addition to its FDA-cleared marking system, the company is advancing next-generation ablation and injection technologies intended to reduce the need for more invasive surgical procedures. TriSalus markets its products primarily within the United States through both direct sales and select distribution partners, while evaluating opportunities for broader global expansion.

TriSalus Life Sciences is led by a management team with deep experience in medical device development, oncology treatment modalities and regulatory affairs. The board of directors and advisory team comprise professionals drawn from established pharmaceutical and medical technology organizations, supporting the company’s mission to enhance patient outcomes through innovation in radiation-based cancer care.

Key Stats

• Today's Range: $1.56 to $1.56
• 50-Day Range: $1.51 to $2.40
• 52-Week Range: $0.42 to $5.00
• Volume: 259 shs
• Average Volume: 9,450 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TLSIW Stock Analysis - Frequently Asked Questions

How have TLSIW shares performed this year?

TriSalus Life Sciences' stock was trading at $1.10 at the beginning of the year. Since then, TLSIW stock has increased by 41.8% and is now trading at $1.56.

How do I buy shares of TriSalus Life Sciences?

Shares of TLSIW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:TLSIW
• CIK: 1826667
• Web: trisaluslifesci.com
• Phone: 888-321-5212
• Fax: N/A
• Employees: 106
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $35.99 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A